IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy

Published:2009-06-25 Issue:11 Volume:24 Page:3540-3542
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Jacquet A.,Francois H.,Frangie C.,Yahiaoui Y.,Ferlicot S.,Micelli C.,Mariette X.,Durrbach A.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/24/11/3540/6904827/gfp314.pdf

Reference12 articles.

1. Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

2. Anti-tumor necrosis factor ? therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy

3. Renal diseases in ankylosing spondylitis: Review of the literature illustrated by case reports

4. IgA Nephropathy

5. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-α antibody drugs for Crohn’s disease: three case reports and literature review;CEN Case Reports;2023-11-30

2. Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports;Journal of Clinical Medicine;2023-04-06

3. Comparison of clinical and pathological features of secondary IgA nephropathy of ankylosing spondylitis and primary IgA nephropathy;Clinical Nephrology;2022-05-01

4. Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature;Biologics: Targets and Therapy;2021-03

5. Onset of IgA nephropathy in a patient treated with infliximab for ankylosing spondylitis;BMJ Case Reports;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3